These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18160309)

  • 1. GMP production and characterization of the bivalent anti-human T cell immunotoxin, A-dmDT390-bisFv(UCHT1) for phase I/II clinical trials.
    Woo JH; Liu JS; Kang SH; Singh R; Park SK; Su Y; Ortiz J; Neville DM; Willingham MC; Frankel AE
    Protein Expr Purif; 2008 Mar; 58(1):1-11. PubMed ID: 18160309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.
    Urieto JO; Liu T; Black JH; Cohen KA; Hall PD; Willingham MC; Pennell LK; Hogge DE; Kreitman RJ; Frankel AE
    Protein Expr Purif; 2004 Jan; 33(1):123-33. PubMed ID: 14680969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-level expression and purification of the recombinant diphtheria fusion toxin DTGM for PHASE I clinical trials.
    Frankel AE; Ramage J; Latimer A; Feely T; Delatte S; Hall P; Tagge E; Kreitman R; Willingham M
    Protein Expr Purif; 1999 Jun; 16(1):190-201. PubMed ID: 10336877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of variant diphtheria toxin-interleukin-3 fusion protein, DTIL3K116W, for phase I clinical trials.
    Su Y; Li SY; Ghosh S; Ortiz J; Hogge DE; Frankel AE
    Biologicals; 2010 Jan; 38(1):144-9. PubMed ID: 19783458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimization of aggregation of secreted bivalent anti-human T cell immunotoxin in Pichia pastoris bioreactor culture by optimizing culture conditions for protein secretion.
    Woo JH; Liu YY; Neville DM
    J Biotechnol; 2006 Jan; 121(1):75-85. PubMed ID: 16107287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing secretion of a bivalent anti-T-cell immunotoxin by Pichia pastoris.
    Woo JH; Liu YY; Stavrou S; Neville DM
    Appl Environ Microbiol; 2004 Jun; 70(6):3370-6. PubMed ID: 15184133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene optimization is necessary to express a bivalent anti-human anti-T cell immunotoxin in Pichia pastoris.
    Woo JH; Liu YY; Mathias A; Stavrou S; Wang Z; Thompson J; Neville DM
    Protein Expr Purif; 2002 Jul; 25(2):270-82. PubMed ID: 12135560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical studies in rats and squirrel monkeys for safety evaluation of the bivalent anti-human T cell immunotoxin, A-dmDT390-bisFv(UCHT1).
    Woo JH; Bour SH; Dang T; Lee YJ; Park SK; Andreas E; Kang SH; Liu JS; Neville DM; Frankel AE
    Cancer Immunol Immunother; 2008 Aug; 57(8):1225-39. PubMed ID: 18256829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation of bivalent anti-T cell immunotoxin from Pichia pastoris glycoproteins by borate anion exchange.
    Woo JH; Neville DM
    Biotechniques; 2003 Aug; 35(2):392-8. PubMed ID: 12951782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GMP production and characterization of leucine zipper-tagged tumor necrosis factor-related apoptosis-inducing ligand (LZ-TRAIL) for phase I clinical trial.
    Jiang J; Liu X; Deng L; Zhang P; Wang G; Wang S; Liu H; Su Y
    Eur J Pharmacol; 2014 Oct; 740():722-32. PubMed ID: 24929054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved binding of a bivalent single-chain immunotoxin results in increased efficacy for in vivo T-cell depletion.
    Thompson J; Stavrou S; Weetall M; Hexham JM; Digan ME; Wang Z; Woo JH; Yu Y; Mathias A; Liu YY; Ma S; Gordienko I; Lake P; Neville DM
    Protein Eng; 2001 Dec; 14(12):1035-41. PubMed ID: 11809934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a GMP Phase III purification process for VB4-845, an immunotoxin expressed in E. coli using high cell density fermentation.
    Premsukh A; Lavoie JM; Cizeau J; Entwistle J; MacDonald GC
    Protein Expr Purif; 2011 Jul; 78(1):27-37. PubMed ID: 21421055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic construction and characterization of an anti-monkey CD3 single-chain immunotoxin with a truncated diphtheria toxin.
    Ma S; Hu H; Thompson J; Stavrou S; Scharff J; Neville DM
    Bioconjug Chem; 1997; 8(5):695-701. PubMed ID: 9327133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of anti-CD3 diphtheria immunotoxin in CD3 positive T-cell lymphoma trials.
    Woo JH; Lee YJ; Neville DM; Frankel AE
    Methods Mol Biol; 2010; 651():157-75. PubMed ID: 20686966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted introduction of a diphtheria toxin resistant mutation into the chromosomal EF-2 locus of Pichia pastoris and expression of immunotoxin in the EF-2 mutants.
    Liu YY; Woo JH; Neville DM
    Protein Expr Purif; 2003 Aug; 30(2):262-74. PubMed ID: 12880776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular modification of a recombinant, bivalent anti-human CD3 immunotoxin (Bic3) results in reduced in vivo toxicity in mice.
    Vallera DA; Todhunter D; Kuroki DW; Shu Y; Sicheneder A; Panoskaltsis-Mortari A; Vallera VD; Chen H
    Leuk Res; 2005 Mar; 29(3):331-41. PubMed ID: 15661270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fermentation and purification of recombinant alpha-galactosidase from Pichia pastoris].
    Gao X; Yang J; Li SB; Liu ZP; Zhang YP
    Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):223-6. PubMed ID: 15966326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bispecific recombinant immunotoxin, DT2219, targeting human CD19 and CD22 receptors in a mouse xenograft model of B-cell leukemia/lymphoma.
    Vallera DA; Todhunter DA; Kuroki DW; Shu Y; Sicheneder A; Chen H
    Clin Cancer Res; 2005 May; 11(10):3879-88. PubMed ID: 15897589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of an anti-CD3 single-chain immunotoxin with a truncated diphtheria toxin in a mutant CHO cell line.
    Liu YY; Gordienko I; Mathias A; Ma S; Thompson J; Woo JH; Neville DM
    Protein Expr Purif; 2000 Jul; 19(2):304-11. PubMed ID: 10873546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of recombinant human antithrombin by Pichia pastoris.
    Kuwae S; Ohyama M; Ohya T; Ohi H; Kobayashi K
    J Biosci Bioeng; 2005 Mar; 99(3):264-71. PubMed ID: 16233787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.